Stryker Net Income 2006-2018 | SYK

Stryker annual/quarterly net income history and growth rate from 2006 to 2018. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.
  • Stryker net income for the quarter ending September 30, 2018 was $0.590B, a 35.94% increase year-over-year.
  • Stryker net income for the twelve months ending September 30, 2018 was $1.236B, a 30.52% decline year-over-year.
  • Stryker annual net income for 2017 was $1.02B, a 38.07% decline from 2016.
  • Stryker annual net income for 2016 was $1.647B, a 14.45% increase from 2015.
  • Stryker annual net income for 2015 was $1.439B, a 179.42% increase from 2014.
Stryker Annual Net Income
(Millions of US $)
2017 $1,020
2016 $1,647
2015 $1,439
2014 $515
2013 $1,006
2012 $1,298
2011 $1,345
2010 $1,273
2009 $1,107
2008 $1,148
2007 $1,017
2006 $778
2005 $644
Stryker Quarterly Net Income
(Millions of US $)
Q3 2018 $590
Q2 2018 $452
Q1 2018 $443
Q4 2017 $-249
Q3 2017 $434
Q2 2017 $391
Q1 2017 $444
Q4 2016 $510
Q3 2016 $355
Q2 2016 $380
Q1 2016 $402
Q4 2015 $522
Q3 2015 $301
Q2 2015 $392
Q1 2015 $224
Q4 2014 $260
Q3 2014 $57
Q2 2014 $128
Q1 2014 $70
Q4 2013 $386
Q3 2013 $103
Q2 2013 $213
Q1 2013 $304
Q4 2012 $270
Q3 2012 $353
Q2 2012 $325
Q1 2012 $350
Q4 2011 $401
Q3 2011 $327
Q2 2011 $310
Q1 2011 $307
Q4 2010 $295
Q3 2010 $337
Q2 2010 $319
Q1 2010 $322
Q4 2009 $306
Q3 2009 $229
Q2 2009 $291
Q1 2009 $281
Q4 2008 $278
Q3 2008 $274
Q2 2008 $306
Q1 2008 $291
Q4 2007 $276
Q3 2007 $229
Q2 2007 $269
Q1 2007 $244
Q4 2006 $228
Q3 2006 $188
Q2 2006 $214
Q1 2006 $148
Q4 2005 $178
Q3 2005 $121
Q2 2005 $178
Q1 2005 $167
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $62.796B $12.444B
Stryker Corporation is one of the world's leading medical technology companies and together with its customers, is driven to make healthcare better. The company offers innovative products and services in Orthopaedics, Medical and Surgical, and Neurotechnology and Spine that help improve patient and hospital outcomes.
Stock Name Country Market Cap PE Ratio
Medtronic (MDT) Ireland $124.342B 19.06
Abbott Laboratories (ABT) United States $122.048B 24.73
Boston Scientific (BSX) United States $50.730B 25.64
Baxter (BAX) United States $33.541B 21.66
Zimmer Biomet Holdings (ZBH) United States $23.031B 14.94
Smith & Nephew SNATS (SNN) United Kingdom $16.007B 0.00
ResMed (RMD) United States $14.492B 27.64
Canopy Growth (CGC) Canada $8.934B 0.00
Perrigo (PRGO) Ireland $8.884B 13.48
Bio-Rad Laboratories (BIO) United States $8.054B 51.50
Aurora Cannabis (ACB) Canada $6.462B 35.26
Hill-Rom Holdings (HRC) United States $6.201B 19.66
Haemonetics (HAE) United States $5.495B 48.33
Insulet (PODD) United States $4.770B 0.00
ICU Medical (ICUI) United States $4.529B 25.23
Hutchison China MediTech (HCM) China $4.274B 0.00
GW Pharmaceuticals (GWPH) United Kingdom $3.987B 0.00
Agios Pharmaceuticals (AGIO) United States $3.869B 0.00
Neogen (NEOG) United States $3.219B 48.74
National Vision Holdings (EYE) United States $3.101B 61.33
NuVasive (NUVA) United States $2.972B 27.65
Aphria (APHA) $2.572B 0.00
Quidel (QDEL) United States $2.478B 32.30
NxStage Medical (NXTM) United States $1.924B 0.00
Phibro Animal Health (PAHC) United States $1.476B 20.89
AtriCure (ATRC) United States $1.174B 0.00
Cardiovascular Systems (CSII) United States $1.015B 1462.50
VAREX IMAGING (VREX) United States $0.992B 19.93
Meridian Bioscience (VIVO) United States $0.827B 26.35
PetIQ (PETQ) United States $0.803B 22.83
OraSure Technologies (OSUR) United States $0.793B 44.65
Surmodics (SRDX) United States $0.776B 118.55
Eagle Pharmaceuticals (EGRX) United States $0.755B 24.22
Cerus (CERS) United States $0.719B 0.00
MacroGenics (MGNX) United States $0.710B 0.00
Omeros (OMER) United States $0.623B 0.00
Lantheus Holdings (LNTH) United States $0.590B 18.27
Owens & Minor (OMI) United States $0.558B 6.31
Insys Therapeutics (INSY) United States $0.542B 0.00
LeMaitre Vascular (LMAT) United States $0.518B 25.45
NanoString Technologies (NSTG) United States $0.481B 0.00
TG Therapeutics (TGTX) United States $0.438B 0.00
Evolus (EOLS) United States $0.399B 0.00
Quanterix (QTRX) United States $0.359B 0.00
Utah Medical Products (UTMD) United States $0.327B 21.12
Cytosorbents (CTSO) United States $0.302B 0.00
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.255B 0.00
Surface Oncology (SURF) United States $0.226B 0.00
Rockwell Medical (RMTI) United States $0.211B 0.00
BioLife Solutions (BLFS) United States $0.206B 278.75
Bovie Medical (BVX) United States $0.201B 0.00
Chimerix (CMRX) United States $0.161B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.148B 0.00
Fonar (FONR) United States $0.139B 6.96
Chembio Diagnostics (CEMI) United States $0.104B 0.00
Imprimis Pharmaceuticals (IMMY) United States $0.081B 0.00
United-Guardian (UG) United States $0.079B 16.63
Female Health (VERU) United States $0.079B 0.00
Trinity Biotech (TRIB) Ireland $0.077B 24.40
Oramed Pharmaceuticals (ORMP) Israel $0.070B 0.00
InfuSystems Holdings (INFU) United States $0.067B 0.00
CAS Medical Systems (CASM) United States $0.056B 0.00
Neurotrope (NTRP) United States $0.050B 0.00
ImmuCell (ICCC) United States $0.041B 0.00
Capricor Therapeutics (CAPR) United States $0.028B 0.00
Myomo (MYO) United States $0.025B 0.00
Valeritas Holdings (VLRX) United States $0.021B 0.00
Senestech (SNES) United States $0.019B 0.00
InVivo Therapeutics Holdings (NVIV) United States $0.019B 0.00
Cellectar Biosciences (CLRB) United States $0.009B 0.00
NeuroMetrix (NURO) United States $0.007B 0.00
Akers Biosciences Inc (AKER) United States $0.000B 0.00